Form 4: LivaNova Director Reports Share Transactions

LivaNova PLC director Barry James Christopher reported transactions involving ordinary shares and restricted stock units on June 15, 2026.

Summary

• Barry James Christopher, a Director at LivaNova PLC, reported several transactions on June 15, 2026.
• These transactions involved the settlement of vested restricted stock units (RSUs) into ordinary shares.
• A total of 4,042 ordinary shares were acquired upon settlement of RSUs, with no cost basis indicated for these shares.
• Additionally, 486 ordinary shares were disposed of to satisfy tax liabilities, with a reported value of $79.7 per share.
• Following these transactions, Mr. Christopher beneficially owns 7,918 ordinary shares directly.
• The filing also notes the grant of RSUs under the 2025 Director Incentive Award Plan, with some vesting on June 15, 2026, and others scheduled to vest on June 15, 2027.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as it represents routine insider transactions related to compensation rather than significant strategic shifts or performance indicators.

Positives

• Vested restricted stock units were settled, resulting in the acquisition of ordinary shares.
• The company has a structured incentive plan (2025 Director Incentive Award Plan) for its directors.
• Transactions were executed according to a plan, potentially satisfying Rule 10b5-1(c) affirmative defense conditions.

Negatives

• 486 ordinary shares were disposed of to cover tax liabilities, indicating a cash outflow or reduction in holdings for tax purposes.

Risks

• Continued service is a condition for the vesting of certain RSUs scheduled for June 15, 2027.
• The value of shares withheld for tax liabilities ($79.7) could fluctuate, impacting the net shares received.

Future Outlook

The filing indicates that 2,383 RSUs granted under the 2025 Plan are scheduled to vest on June 15, 2027, contingent upon continued service.

Management Comments

• Reporting person had vested restricted stock units (RSUs) settled in ordinary shares of LivaNova PLC (the Company), 1.00 GBP par value.
• Each RSU represents a contingent right to receive one ordinary share of the Company in accordance with the terms of the Company's 2025 Director Incentive Award Plan (the 2025 Plan) and the 2025 Plan award agreement.
• Shares withheld to satisfy tax liability.
• RSUs granted under the 2025 Plan on June 15, 2025 that vested on June 15, 2026.
• The RSUs, granted under the 2025 Plan, vest on June 15, 2027, subject to continued service during the vesting period and the terms of the 2025 Plan award agreement.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for insider transactions, providing transparency into how company executives and directors manage their holdings. The settlement of RSUs is a common component of executive compensation packages in the healthcare technology sector.

Corporate Governance

Stakeholder Impact

• Shareholders: Increased transparency into director holdings and compensation practices.
• Employees: Reinforces the company's use of equity-based compensation for leadership.
• Management: Direct impact on personal holdings and tax obligations.

Next Steps

• Continued service by Barry James Christopher is required for the vesting of 2,383 RSUs on June 15, 2027.

Key Dates

Keywords

LivaNova PLC, Form 4, Insider Trading, Share Transactions, Restricted Stock Units, Director Compensation, Securities Exchange Act, LIVN